Last reviewed · How we verify

Bipolar Disorder — Treatment Landscape & Competitive Intelligence

Bipolar Disorder (Psychiatry) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Psychiatry 5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Bipolar Disorder, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Lithium Citrate LITHIUM CITRATE Hikma lithium Glycogen synthase kinase-3 1980-01-01
Lithobid lithium carbonate Generic (multiple manufacturers) Mood stabilizer Inositol-1(or 4)-monophosphatase 1, Glycogen synthase kinase-3 1970-04-06
Seroquel quetiapine AstraZeneca Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Seroquel Seroquel University of Pittsburgh Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A
Quetiapin Quetiapin Sykehuset Innlandet HF Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 2 drugs in Bipolar Disorder
  2. AstraZeneca · 1 drug in Bipolar Disorder
  3. Generic (multiple manufacturers) · 1 drug in Bipolar Disorder
  4. Hikma · 1 drug in Bipolar Disorder
  5. Sykehuset Innlandet HF · 1 drug in Bipolar Disorder
  6. University of Pittsburgh · 1 drug in Bipolar Disorder

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Bipolar Disorder:

Cite this brief

Drug Landscape (2026). Bipolar Disorder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/bipolar-disorder. Accessed 2026-05-13.

Related